| value |
{"aggregator_url":"https://www.sec.gov {"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1130598/0002125562-26-000004.txt","as_of":"2026-04-09T03:12:49.786272+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1130598/0002125562-26-000004.txt","company":"Traws Pharma, Inc.","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1130598/0002125562-26-000004.txt","article_chars":3149,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_e544c1cfd27eee21","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1130598/0002125562-26-000004.txt","content_type":"text/plain","enriched_at":"2026-04-09T16:32:00.574699+00:00","extraction_method":"heuristic","fetched_description":"","fetched_title":"","final_url":"https://www.sec.gov/Archives/edgar/data/1130598/0002125562-26-000004.txt","html_truncated":false,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1130598/0002125562-26-000004.txt","source_event_id":"evt_54fb3e93f28b","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"form_type":"4","fp":"9bec398d694449f7","kind":"sec_filing","published_at":"20260408","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.78,"dates_mentioned":["2026-04-08","2026-04-09T03:12:49.786272+00:00","2025-10-12","2025-12-12","2026-03-08","20090526","20001226","2026-10-12","2026-12-12","2027-03-08","2035-10-12","2035-12-12","2036-03-08","2025-12-12","2025-10-12"],"entities":[{"asset_class":"equity","name":"Traws Pharma, Inc.","relevance":"high","symbol":"TRAW","type":"issuer"},{"asset_class":"person","name":"Charles N. Parker","relevance":"high","symbol":"","type":"reporting_person"},{"asset_class":"person","name":"Parker Charles Nolan","relevance":"medium","symbol":"","type":"reporting_person_name_variant"}],"event_type":"listing","information_gaps":["What changed vs prior known state is not provided in the signal; no prior filing details are included for comparison.","The cleaned text includes quantities and strike prices (e.g., 3.01, 2.33, 1.60) but the mapping of each numeric value to each specific award is not fully structured in the provided text; only the presence of these values is evident.","No explicit statement of whether these are new grants vs exercises/sales is provided beyond the described award types (RSUs and stock options)."],"key_facts":["SEC accession number: 0002125562-26-000004.","Issuer: Traws Pharma, Inc. (TRAW).","Filing form type: Form 4.","Filed as of date: 2026-04-08; conforming period of report: 2025-10-12.","Reporting person: Parker Charles Nolan; listed title: Chief Financial Officer.","The filing includes an RSU award described as restricted stock units that vest 100% on the first anniversary of the grant date and convert one-for-one into common stock.","The filing includes stock option awards under the Issuer\u2019s 2021 Incentive Compensation Plan (as amended through the date hereof).","For the stock option awards, the text states they vest 100% on the first anniversary of the grant date.","The filing shows multiple option grant entries with grant dates including 2025-10-12, 2025-12-12, and 2026-03-08, and corresponding expiration dates shown as 2035-10-12, 2035-12-12, and 2036-03-08 (as presented in the cleaned text)."],"numeric_claims":[{"label":"RSU/option quantity shown for one entry (common stock)","value":"15393"},{"label":"Option quantity shown for another entry (common stock)","value":"32406"},{"label":"Option quantity shown for another entry (common stock)","value":"61571"},{"label":"Option quantity shown for another entry (common stock)","value":"104544"}],"primary_claim":"On 2026-04-08, Traws Pharma, Inc. filed Form 4 reporting equity awards to Charles N. Parker, including RSUs and stock options with vesting on the first anniversary of the grant date.","relevance_score":0.45,"sentiment":"neutral","source_quality":"high","summary":"Traws Pharma, Inc. (TRAW) filed a Form 4 on 2026-04-08 reporting equity awards by reporting person Charles N. Parker (CFO). The filing discloses multiple stock option grants and one restricted stock unit (RSU) award with specified grant/vesting terms.","topics":["SEC Form 4","insider equity awards","stock options","restricted stock units (RSUs)","vesting terms","2021 Incentive Compensation Plan"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 4 \u00b7 Traws Pharma, Inc. \u00b7 Filed 20260408","ticker":"TRAW","tickers":["TRAW"],"title":"TRAW filed 4","url":"https://www.sec.gov/Archives/edgar/data/1130598/0002125562-26-000004.txt"}... |